Source: International Congress 2016 – Studies in airway cell biology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Robert Newton (Calgary, AB, Canada), Mahmoud Mostafa, Rider Christopher, Leigh Richard, Robert Newton. Glucocorticoid-induced transcriptional regulators in human airway cells and airways. Eur Respir J 2016; 48: Suppl. 60, 3988

Member's Comments

No comment yet.

Related content which might interest you: Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Anti-inflammatory action of Gibberellin in lung epithelial cells is mediated by modification of NF-κB related kinase expression Source: International Congress 2014 – Mechanistic studies of the airway epithelium Year: 2014 Inhibitors of apoptosis proteins in asthmatic airway inflammation Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Glucocorticoids and indacaterol regulated gene expressions profiling in human bronchial epithelial cells Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Inhibition of phosphodiesterase 4B enhances glucocorticoid-dependent gene transcription in human airway epithelial cells: Implications for the treatment of COPD Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Azithromycin augments rhinovirus-induced expression of IFNbeta and IFNλ1 in asthmatic bronchial epithelial cells by up-regulating RIG-I like receptors Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Regulation of inflammatory cytokines in human immunocompetent cells by propranolol in vitro Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 COPD airway epithelium secretion attracts and activates neutrophils Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Aerobic training reverses airway inflammation by increasing the expression of anti-inflammatory cytokines by peribronchial cells but not by skeletal muscle Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 cPLA2alpha inhibitor ASB14780 suppresses airway MMP-9 production and improves respiratory function in cigarette-smoke induced model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Compound A modulates steroid insensitive chemokines in airway smooth muscle cells via IRF-1 dependent and independent pathways Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Potential role of SPARC, a downstream mediator of TGF-b in chronic airways disease Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstriction Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Vitamin D increases anti-microbial activity in human airway epithelial cells Source: International Congress 2014 – Mechanistic studies of the airway epithelium Year: 2014 A role for the WFDC protein, WAP2, in regulation of innate host defence in the lung Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Anti-inflammatory effects of the novel phosphodiesterase type 4 inhibitor CHF6001 on COPD alveolar macrophages and lung tissue Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014